MJARF (MJardin Group) ROE % Adjusted to Book Value: 0.00% (As of Sep. 2021)


What is MJardin Group ROE % Adjusted to Book Value?

MJardin Group MJARF -99.00% ROE % Adjusted to Book Value is 0.00% as of Sep. 2021.

MJardin Group's ROE % for the quarter that ended in Sep. 2021 was 0.00%. MJardin Group's PB Ratio for the quarter that ended in Sep. 2021 was N/A. MJardin Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 was N/A.


MJardin Group ROE % Adjusted to Book Value Related Terms


MJardin Group ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for MJardin Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MJardin Group ROE % Adjusted to Book Value Chart

MJardin Group Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Dec19 Dec20
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MJardin Group Quarterly Data
Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity 0.00 0.00 0.00 0.00

MJARF vs EAPH, FPSUF, GCAN: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MJardin Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MJardin Group ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MJardin Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MJardin Group's ROE % Adjusted to Book Value falls into.



MJardin Group ROE % Adjusted to Book Value Calculation

MJardin Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

MJardin Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
MJardin Group (MJARF) has a ROE % Adjusted to Book Value of 0.00% as of Sep. 2021. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MJardin Group and its competitors.
Is MJardin Group's ROE % Adjusted to Book Value too high?
MJardin Group's current ROE % Adjusted to Book Value is 0.00%.
How does MJardin Group's ROE % Adjusted to Book Value compare to EAPH and FPSUF?
MJardin Group's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MJardin Group and its competitors. MJardin Group's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MJardin Group stock overvalued right now?
MJardin Group (MJARF) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MJardin Group (MJARF), the current ROE % Adjusted to Book Value is 0.00% as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MJardin Group Business Description

Address 1 Toronto Street, Suite 801, Toronto, ON, CAN, M5C 2V6
MJardin Group Inc is a Canada based cannabis cultivation and management company. It is engaged in the cultivation, processing, and distribution of medical cannabis. The company's operating segment includes Cultivation management in USA and Cultivation operations in Canada. It generates maximum revenue from the Cultivation management in USA segment. Cultivation management in USA segment engaged in the management services to owners of cultivation and dispensary facilities. The services provided are consulting, design, operational, and other management services.